 |
|
Safety of Antihistamines in the Treatment of Allergic Rhinitis in Elderly Patients
Jack D. McCue, MD
Arch Fam Med. 1996;5(8):464-468.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Salvaggio JE. Allergic rhinitis. In: Wyngaarden JB, Smith LH Jr, Bennett JC, eds. Cecil Textbook of Medicine. 19th ed. Philadelphia, Pa: WB Saunders Co; 1992:1457-1462.
2. Austen KF. Diseases of immediate hypersensitivity. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill Inc; 1991: 1422-1428. 3. Olin BR, Hebel SK, Dombek CE, Kastrup EK, eds. Facts and Comparisons. St Louis, Mo: Facts and Comparisons Inc; 1993:801. 4. Garrison JG. Histamine, bradykinin, 5-hydroxy-tryptamine, and their antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press; 1990:575-599. 5. Barnett A, Kreutner W. Pharmacology of nonsedating H, antihistamines. In: New Perspectives in Histamine Research. Basel, Switzerland: Birkhauser Verlag; 1991:181-196. 6. Physicians' Desk Reference. 50th ed. Montvale, NJ: Medical Economics Data Production Company; 1996. 7. Bousquet J. Clinical activity of and side effects of loratadine in patients with seasonal allergic rhinitis. Presented at the 44th Annual Conference, American College of Allergists; November 1987; Boston, Mass. Abstract. 8. Kaminszczik I, Soto-Roman L, Kutwak, et al. Loratadine vs astemizole: onset of allergy symptoms relief. Presented at the XIIIth Congress of the European Academy of Allergology and Clinical Immunology; May 1986; Budapest, Hungary. Abstract. 9. Oei HD, Verheij E, Schwab D, Lherminier M, Bruynzeel PLB. A comparative study of the efficacy of loratadine (L) and astemizole (A). J Allergy Clin Immunol. 1987;79:190. Abstract.
10. Bruttmann G, Pedrali P. Loratadine (SCH 29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis. J Int Med Res. 1987;15:63-70.
PUBMED
11. Gutowski A, Bedard P, Carpio JD, et al. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1988;81:902-907.
PUBMED
12. Horak F, Bruttmann G, Pedrali P, et al. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Arzneimittelforschung. 1988;38:124-128.
PUBMED
13. Passaleva A, Ricci M. Loratadine, a new antihistamine drug in seasonal allergic rhinitis. Allergy. 1988;43(suppl7):111.
14. Simons FE, Simons KJ. H1 receptor antagonist treatment of chronic rhinitis. J Allergy Clin Immunol. 1988;81:975-980.
PUBMED
15. Hilbert J, Moritzen V, Parks A, et al. The pharmacokinetics of loratadine in normal geriatric volunteers. J Int Med Res. 1988;16:50-60.
PUBMED
16. Radwanski E, Hilbert J, Symchowicz S, Zampaglione N. Loratadine: multiple-dose pharmacokinetics. J Clin Pharmacol. 1987;27:530-533.
ABSTRACT
17. Hilbert J, Radwanski E, Weglein R, et al. Pharmacokinetics and dose-proportionality of loratadine. J Clin Pharmacol. 1987;27:694-698.
ABSTRACT
18. Clissold SP, Sorkin EM, Goa KL. Loratadine: a preliminary review of its pharmacokinetic properties and therapeutic efficacy. Drugs. 1989;37:42-57.
PUBMED
19. Smith SJ. Cardiovascular toxicity of antihistamines. Otolaryngol Head Neck Surg. 1994;111:348-354.
PUBMED
20. Zechnich AD, Hedges JR, Eiselt-Proteau D, Haxby D. Possible interaction with terfenadine or astemizole. West J Med. 1994;160:321-325.
PUBMED
21. Paris DG, Parente TF, Bruschetta HR, Guzman E, Niarchos AP. Torsades de pointes induced by erythromycin and terfenadine. Am J Emerg Med. 1994;12:636-638.
PUBMED
22. Affrime MB, Lorber R, Danzig M, Cuss F, Brannan MD. Three month evaluation of electrocardiographic effects of loratadine in humans. J Allergy Clin Immunol. 1993;91:259. Abstract.
23. Ryhal BT, Fletcher MP. The second-generation antihistamines: what makes them different? Postgrad Med. 1991;89:87-99.
PUBMED
24. Roth T, Roehers T, Koshorek G, Sicklesteel J, Zorick T. Sedative effects of antihistamines. J Allergy Clin Immunol. 1987;80:94-98.
PUBMED
25. Adelsberg BR, D'Amico-Beadon A. The effects of loratadine, diphenhydramine and placebo on worker productivity: results of a double-blind trial. J Allergy Clin Immunol. 1990;85:296. Abstract.
26. Dockhorn RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (SCH-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy. 1987;58:407-411.
PUBMED
27. Neves-Pinto RM, Moreira Lima G, da Mota Teixeira R. A double-blind study of the effects of loratadine versus placebo on the performance of pilots. Am J Rhinol. 1992;6:23-27.
28. DeRoeck J, Cluydts R, Herman P. Effects of antihistamines on daytime alertness. J Allergy Clin Immunol. 1990;85:179. Abstract.
29. Chervinsky P, Georgitis J, Banov C, Boggs P, Vande Stouwe R, Greenstein S. Once daily loratadine versus astemizole once daily. Ann Allergy. 1994;73:109-113.
PUBMED
30. Falliers CJ, Brandon ML, Buchman E, et al. Doubleblind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy. 1991;66:257-262.
PUBMED
31. Gengo FM, Gabos C, Mechler L. Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator. Ann Allergy. 1990;64:520-526.
PUBMED
32. Walsh JK, Muehlbach MG, Schweitzer PK. Simulated assembly line performance following ingestion of cetirizine or hydroxyzine. Ann Allergy. 1992;69:195-200.
PUBMED
33. Van Cauwenberge PB. New data on the safety of loratadine. Drug Invest. 1992;4:283-291.
34. Ramaekers JG, Uiterwijk MM, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42:363-369.
PUBMED
35. Hilbert JM, Matzke GR, Radwanksi E, et al. Loratadine pharmacokinetics in renal impairment. J Allergy Clin Immunol. 1987;79:206. Abstract.
36. Campoli-Richards DM, Buckley MM-T, Fitton A. Cetirizine: a review of its pharmacologic properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs. 1990;40:762-781.
PUBMED
37. Hébert J, Bédard P-M, Del Carpio PJ, et al. Loratadine and pseudoephedrine sulfate: a doubleblind, placebo-controlled comparison of a combination tablet (SCH434) and its individual components in seasonal allergic rhinitis. Am J rhinol. 1988;2:71-75.
38. Grossman J, Bronsky EA, Lanier BQ, et al. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis. Ann Allergy. 1989;63:317-321.
PUBMED
39. Bennet DR, ed. Drug Evaluations Annual 1991. Milwaukee, Wis; American Medical Association: 1990. 40. Tan R, Corren J. Optimum treatment of rhinitis in the elderly. Drugs Aging. 1995;7:168-175.
PUBMED
|
